AbbVie Inc (ABBV)
176.93
+5.20
(+3.03%)
USD |
NYSE |
Nov 22, 16:00
177.44
+0.51
(+0.29%)
After-Hours: 18:10
AbbVie Free Cash Flow: 15.62B for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | 15.62B |
| June 30, 2024 | 17.78B |
| March 31, 2024 | 21.89B |
| December 31, 2023 | 22.06B |
| September 30, 2023 | 24.73B |
| June 30, 2023 | 24.80B |
| March 31, 2023 | 23.52B |
| December 31, 2022 | 24.25B |
| September 30, 2022 | 21.92B |
| June 30, 2022 | 22.21B |
| March 31, 2022 | 22.05B |
| December 31, 2021 | 21.99B |
| September 30, 2021 | 21.68B |
| June 30, 2021 | 19.57B |
| March 31, 2021 | 17.79B |
| December 31, 2020 | 16.79B |
| September 30, 2020 | 15.33B |
| June 30, 2020 | 14.12B |
| March 31, 2020 | 13.55B |
| December 31, 2019 | 12.77B |
| September 30, 2019 | 12.93B |
| June 30, 2019 | 12.77B |
| March 31, 2019 | 13.17B |
| December 31, 2018 | 12.79B |
| September 30, 2018 | 11.92B |
| Date | Value |
|---|---|
| June 30, 2018 | 10.82B |
| March 31, 2018 | 9.95B |
| December 31, 2017 | 9.431B |
| September 30, 2017 | 8.456B |
| June 30, 2017 | 6.652B |
| March 31, 2017 | 6.562B |
| December 31, 2016 | 6.562B |
| September 30, 2016 | 6.953B |
| June 30, 2016 | 7.64B |
| March 31, 2016 | 7.57B |
| December 31, 2015 | 7.003B |
| September 30, 2015 | 4.454B |
| June 30, 2015 | 4.032B |
| March 31, 2015 | 3.89B |
| December 31, 2014 | 2.937B |
| September 30, 2014 | 4.762B |
| June 30, 2014 | 4.821B |
| March 31, 2014 | 5.164B |
| December 31, 2013 | 5.776B |
| September 30, 2013 | 5.528B |
| June 30, 2013 | 6.13B |
| March 31, 2013 | 5.679B |
| December 31, 2012 | 6.012B |
| September 30, 2012 | 6.110B |
| June 30, 2012 | 5.549B |
Free Cash Flow Range, Past 5 Years
12.77B
Minimum
Dec 2019
24.80B
Maximum
Jun 2023
19.72B
Average
21.78B
Median
Free Cash Flow Benchmarks
| Amgen Inc | 6.283B |
| Johnson & Johnson | 19.02B |
| Eli Lilly and Co | -2.275B |
| Merck & Co Inc | 14.84B |
| Pfizer Inc | 8.227B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 5.447B |
| Cash from Investing (Quarterly) | -8.256B |
| Cash from Financing (Quarterly) | -3.072B |
| Free Cash Flow Per Share (Quarterly) | 2.933 |
| Free Cash Flow to Equity (Quarterly) | 4.753B |
| Free Cash Flow to Firm (Quarterly) | 5.642B |
| Free Cash Flow Yield | 4.98% |